regadenoson has been researched along with Dizziness in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hage, FG; Heo, J; Iskandrian, AE | 1 |
| Alqaid, A; Dick, R; Doukky, R; Morales Demori, R; Rangel, MO; Wassouf, M | 1 |
1 review(s) available for regadenoson and Dizziness
| Article | Year |
|---|---|
The safety and tolerability of regadenoson in patients with end-stage renal disease: the first prospective evaluation.
Topics: Adenosine A2 Receptor Agonists; Comorbidity; Diarrhea; Dizziness; Drug-Related Side Effects and Adverse Reactions; Exercise Test; Female; Humans; Incidence; Kidney Failure, Chronic; Male; Middle Aged; Myocardial Perfusion Imaging; Pilot Projects; Prospective Studies; Purines; Pyrazoles; Randomized Controlled Trials as Topic; Risk Factors; Tomography, Emission-Computed, Single-Photon; United States; Vasodilator Agents | 2013 |
1 other study(ies) available for regadenoson and Dizziness
| Article | Year |
|---|---|
Use of regadenoson in end-stage renal disease.
Topics: Diarrhea; Dizziness; Exercise Test; Female; Humans; Kidney Failure, Chronic; Male; Myocardial Perfusion Imaging; Purines; Pyrazoles; Tomography, Emission-Computed, Single-Photon | 2013 |